News Focus
News Focus
Followers 175
Posts 3500
Boards Moderated 1
Alias Born 11/03/2014

Re: Maverick0408 post# 449968

Wednesday, 03/09/2022 2:48:16 PM

Wednesday, March 09, 2022 2:48:16 PM

Post# of 823770
I disagree Maverick0408, if Linda Powers and the rest of the NWBio management team, can continue to execute on the following:

(1) successfully navigate through all the challenges and obstacles inherent in completing a multi-national Phase III clinical trial, in 4 different countries (US, UK, Canada, Germany) for 1 of the most difficult to treat diseases in the world, and where dozens of other large & small pharmaceutical companies, who have tried since 2005 have failed;

(2) overcome the torrrent of resistance from legal and illegal shorts, hedge funds, and other who have been actively and aggressively trying to stop NWBio from succeeding;

(3) overcome the barrage of coordinated and concerted disinformation, misinformation and outright lies about NWBio and the DCVax vaccine platform, all across social media, message boards, chat roooms, etc;

(4) finally, release positive DCVax-L TLD and journal article; and

(5) Obtain regulatory approvals for DCVax-L in the US, UK, Canada, Germany and the rest of the EU.

Others may hop off this train after TLD and a nice pop in NWBO share price. There is nothing wrong with that, and that is totally their decision.

I will continue to ride with this management team beyond this first phase of success (regulatory approval in the US, UK, Canada, Germany and the rest of the EU), until the facts on the ground tells me that they have stopped executing their additional business plans (DCVax Direct positive trials & approvals, DCVax-L approvals for other solid tumor cancers, etc.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News